These results suggest interplay between the ERK/MAPK signaling pathway and BANCR in PTC, highlighting BANCR as a potential therapeutic target for the treatment of BRAFV600E-positive thyroid cancer. The gene discussed is BANCR; the disease is thyroid cancer.